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ABSTRACT
INTRODUCTION Electronic cigarette (e-cigarette) use has grown 
significantly in some European Union (EU) Member States 
(MS). A better understanding of the exposure to secondhand 
e-cigarette aerosols (SHA) is necessary to develop and 
implement comprehensive regulations on e-cigarette use in 
public places. This study aims to assess the observation of 
e-cigarette use in public places, the self-reported exposure to 
SHA, and the level of users’ comfort using e-cigarettes in the 
presence of others.
METHODS This is a cross-sectional study of the Wave 1 International 
Tobacco Control 6 European Countries Survey recruiting 
adult smokers (n=6011) across six EU MS: Germany, Greece, 
Hungary, Poland, Romania, and Spain, within the EUREST-
PLUS Project. A descriptive analysis was conducted to estimate 
the prevalence (%) of observed e-cigarette use in different 
places, frequency of self-reported exposure to SHA, and level 
of comfort using e-cigarettes in the presence of others. 
RESULTS In all, 31.0% of smokers observed others using e-cigarette 
in public places, 19.7% in indoor places where smoking is 
banned, and 14.5% indoors at work. Almost 37% of smokers 
reported to be ever exposed to SHA, ranging from 17.7% in 
Spain to 63.3% in Greece. The higher prevalence of observed 
e-cigarette use and passive exposure to SHA was reported 
by smokers of younger age, of higher educational level and 
those being current or former e-cigarette users. Part (8.8%) of 
the smokers who were also e-cigarette users reported feeling 
uncomfortable using e-cigarettes in the presence of others.
CONCLUSIONS A third of smokers from six EU MS reported being 
exposed to SHA. Prevalence differences were observed among 
the countries. In the context of scarce evidence on long-term 
health effects of exposure to SHA, precautionary regulations 
protecting bystanders from involuntary exposure should be 
developed. 
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INTRODUCTION
Electronic cigarettes (e-cigarettes) are relatively 
new in the market of nicotine and tobacco products; 
nevertheless, awareness about these devices 
and prevalence of their use is growing in some 
European Union (EU) Member States (MS)1. While 
the health effects of active e-cigarette use have 
received substantial attention in research, evidence 
concerning the impact on the health of bystanders 
exposed to secondhand e-cigarette aerosols (SHA) is 
relatively scarce2. 
SHA (mainstream aerosol exhaled by e-cigarette 
users) contains a number of toxic components, among 
them: propylene glycol, glycerol, formaldehyde, 
acetaldehyde, nicotine, particulate matter, polyaromatic 
hydrocarbons, volatile organic compounds (VOC), 
tobacco-specific nitrosamines, acrolein, and metals 
such as copper, cadmium, nickel and lead3. The 
World Health Organisation (WHO) suggests that 
even though it is unknown whether exposure to the 
toxic components of SHA leads to an increased risk 
of morbidity and mortality among bystanders, the 
epidemiological evidence of the negative health effects 
of some of its components (e.g. fine particles and 
nicotine) is well-established and cannot be neglected4. 
A population-based study conducted in Italy in 
2017 found that 13.7% of e-cigarette non-users were 
exposed to SHA in various indoor settings on a daily 
basis5. This shows that despite the relatively low 
prevalence of active e-cigarette use (1.1%) in that 
country, passive exposure was considerably high5. 
This might be that in many public places the use of 
e-cigarettes is still not regulated and these devices 
are used in settings where the use of combustible 
tobacco cigarettes is forbidden6. 
The Seventh Session of the Conference of Parties 
to the WHO Framework Convention on Tobacco 
Control (FCTC) has suggested some policy options 
for countries to regulate e-cigarette use in public 
places; one is to ban the use of e-cigarettes in areas 
where smoking is prohibited7. As of October 2017, 
20 EU MS had national regulations regarding 
e-cigarette use in public places8, and whilst the 
prevalence of use is monitored1, there is almost no 
information about exposure of bystanders.
Knowledge of the actual exposure of the 
population to SHA is necessary to formulate 
comprehensive regulations on e-cigarette use in 
public places. Therefore, the objective of this study 
was to improve current knowledge on exposure to 
SHA in Europe with regard to observed e-cigarette 
use in public places, self-reported exposure to 
e-cigarette aerosols, and degree of users’ comfort 
near other people.
METHODS
Design 
This study is part of the European Regulatory 
Science on Tobacco: Policy implementation to reduce 
lung diseases (EUREST-PLUS) Project that aims 
to evaluate the impact of the EU Tobacco Products 
Directive (TPD)9 within the context of the WHO 
FCTC10 ratification at a European level. One of the 
objectives of the EUREST-PLUS Project is to assess 
the psychosocial and behavioural impact of TPD and 
FCTC implementation through the inception of a 
longitudinal cohort of approximately 6000 smokers 
as part of the International Tobacco Control survey 
(ITC) across six EU MS (ITC 6E)11. The participating 
countries of the EUREST-PLUS ITC 6E cohort are: 
Germany (n=1003), Greece (n=1000), Hungary 
(n=1000), Poland (n=1006), Romania (n=1001), 
and Spain (n=1001). These countries have both 
diverse prevalence and regulation of e-cigarette use 
in public places (Table 1).
Data in this study were derived from the 
baseline (Wave 1) survey that was carried out 
from June to September 2016, recruiting current 
smokers (having smoked >100 cigarettes in their 
lifetime and having smoked at least once in the 
past 30 days) age ≥18 years and using a multi-
stage stratified sample representative of all 
geographical regions in each EU MS. A random 
walk method was used to select eligible households 
where, if possible, male and female smokers 
were chosen using the Next Birthday method for 
interview12. All interviews were conducted using 
tablets (computer-assisted personal interviewing) 
after informed consents from participants were 
obtained. The details of the sampling and survey 
methods of this ITC 6E Wave 1 Survey have been 
presented elsewhere13. The study protocol received 
approval from an ethics committee in each of the 
participating countries and institution partners, and 
was registered at Clinicaltrials.gov (registration 
number NCT02773836).
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Measures
Observed e-cigarette use in public places was 
described based on sites where participants saw 
someone using e-cigarettes. The observed e-cigarette 
use in public places was ascertained from participants 
who knew about e-cigarettes by the question: ‘In the 
last 30 days, how often have you seen someone using 
an e-cigarette or vaping device in public (excluding 
you)?’. Participant answers: ‘Everyday’, ‘Most days’, or 
‘Some days’ were recoded as ‘Yes’; while ‘Rarely’ and 
‘Not at all’ were recoded as ‘No’. Those respondents 
who answered ‘Yes’ were subsequently asked about 
observed e-cigarette use ‘indoors where smoking 
ordinary cigarettes is banned’ with the question: 
‘In the last 30 days, have you seen someone using 
e-cigarettes or vaping devices indoors where smoking 
ordinary cigarettes is banned?’. Possible answers were: 
‘No’, ‘Yes, but only once’, ‘Yes, a few times’, and ‘Yes, 
frequently’. ‘No’ answers from this and the previous 
question were recorded as ‘No’ and the last three 
responses were recoded as ‘Yes’. All respondents who 
knew about e-cigarettes and worked outside home 
were asked about observed e-cigarette use at indoor 
workplaces with the question: ‘In the last 30 days, 
have people used an e-cigarette or vaping device in 
indoor areas where you work?’, with possible answers 
‘Yes’ or ‘No’.
E-cigarette use status was determined with the 
question: ‘Have you ever used an e-cigarette or 
vaping device, even one time?’. The participants who 
responded ‘No’ were classified as ‘never users’. If they 
answered ‘Yes’, a subsequent question was asked: ‘On 
average, how often do you currently use e-cigarettes 
or vaping devices?’; with possible answers: ‘Daily’, 
‘Less than daily, but at least once a week’, ‘Less 
than weekly, but at least once a month’, ‘Less than 
monthly’ (all previous answers recoded as ‘current 
user’), and ‘Not at all’ (recoded as ‘former user’). 
Self-reported frequency of exposure to SHA 
was ascertained by asking non-current e-cigarette 
users (former and never users) with the question: 
‘How often are you exposed to the vapour from 
other people’s e-cigarettes or vaping devices?’; with 
possible answers: ‘Never’, ‘Rarely’, ‘Sometimes’, 
‘Often’, and ‘Very often’.
Comfortability with e-cigarette use around other 
people was determined by asking participants 
who used e-cigarettes at least once a month: ‘How 
comfortable do you feel about using e-cigarettes or 
vaping devices around other people?’; with possible 
answers ‘Very comfortable’, ‘Comfortable’, ‘Neutral’, 
‘Uncomfortable’ ,  and ‘Very uncomfortable’. 
Table 1. National regulation on the e-cigarette use in public places in six European Union Member States
Country
Ever 
e-cigarette 
use (%)*
Current
e-cigarette 
use (%)*
Legislation 
in place**
Year of 
legislation** Comments**
Germany 8 2 No N/A No regulation in place 
Greece 9 3 Yes 2010 The regulation for a ban on smoking in public places includes 
e-cigarettes.
A petition by the Association of Greek E-cigarettes Businesses 
was rejected by Greece’s highest administrative court in decision 
704/2018, upholding that Greece laws on conventional smoking 
also apply to e-cigarettes.
Hungary 6 1 Yes 2016 The ban concerns almost the same venues in which tobacco 
smoking is banned with the exception of areas designated for 
smoking.
Poland 9 1 Yes 2016 Use of e-cigarettes is banned in all indoor public places, including 
hospitality venues and workplaces.
The ban concerns almost the same venues in which tobacco 
smoking is banned.
Romania 7 0 No N/A No regulation in place.
Spain 9 1 Yes 2014 Use of e-cigarettes is banned in all indoor public places, with the 
exception of hospitality venues.
The ban includes use of e-cigarettes in outdoor areas of schools, 
healthcare organizations and children’s playgrounds.
*2017 Eurobarometer Data15 , ** Institute for Global Tobacco Control8. The information was reviewed and extended by local researchers of the study.
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Receiving negative reactions from others to their 
e-cigarette use was also assessed among the same 
participants by asking: ‘In the last 30 days, have 
you received any negative reactions to your using 
e-cigarettes or vaping devices from any of the 
following groups: ‘Strangers’, ‘Work colleagues’, 
‘Friends’, and ‘Family’?’. Response options were ‘Yes’ 
or ‘No’ for each group. 
Sociodemographic characteristics studied were 
country, sex (male, female), age group (18–24, 25–
39, 40–54, ≥55 years old), and level of education 
(low: primary, lower pre-vocational secondary, 
middle pre-vocational secondary; moderate: 
secondary vocational, senior general secondary and 
pre-university; and high: higher professional and 
university Bachelor, university Masters). 
Analysis
A descriptive analysis was conducted to estimate the 
prevalence (%) and 95% confidence intervals (CI) 
of observed e-cigarette use in different places (in 
public in general, in indoor places where smoking 
conventional cigarettes is banned, and in indoor 
areas of workplaces) and frequency (% and 95% CI) 
of SHA exposure according to sociodemographic 
characteristics (country, sex, age groups, and level of 
education) and e-cigarette use status. Additionally, 
comfortability with e-cigarette use around other 
people and receiving negative reactions to e-cigarette 
use were assessed using Pearson’s chi-squared test. 
Statistical significance was set at p<0.05. All analyses 
applied the sample weights to account for the 
complex sample design and were conducted using 
STATA version 13.0.
RESULTS
Observed e-cigarette use 
Among all smokers from six EU MS who had ever 
knew about e-cigarettes, 31.0% had seen people 
using e-cigarettes in public in the last 30 days, and 
19.7% observed people using e-cigarettes in indoor 
places where smoking conventional cigarettes was 
banned (Table 2). The highest level of observed 
e-cigarette use was reported in Greece: 55.2% in 
public and 40.5% in indoor areas where smoking 
was prohibited. The lowest prevalence of observed 
Table 2. Prevalence of observed e-cigarette use in different settings across six European Union Member States, 2016
In public
(n=4142 )
Indoors where smoking is banned
(n=4122 )
Indoor areas at work
(n=2566 )
N n % 95% CI p* N n % 95% CI p* N n % 95% CI p*
All 4142 1244 31.0 (28.5 - 33.5) 4122 804 19.7 (17.8 - 21.6) 2566 362 14.5 (12.6 - 16.4)
Country <0.001 <0.001 <0.001
Germany 629 174 28.2 (22.9 - 33.5) 628 95 15.4 (11.5 - 19.3) 428 35 9.6 (5.7 - 13.6)
Greece 734 416 55.2 (45.9 - 64.5) 733 330 40.5 (33.7 - 47.4) 440 172 37.4 (30.3 - 44.5)
Hungary 652 95 16.3 (9.8 - 22.7) 651 50 9.2 (4.3 - 14.1) 457 19 5.7 (1.3 - 10.0)
Poland 646 283 45.4 (39.8 - 51.1) 631 190 31.4 (26.1 - 36.7) 381 64 15.3 (11.9 - 18.8)
Romania 651 170 29.2 (23.8 - 34.6) 650 88 15.8 (11.6 - 20.1) 386 55 16.2 (11.6 - 20.7)
Spain 830 106 12.3 (9.0 - 15.6) 829 51 5.7 (3.7 - 7.6) 474 17 4.0 (1.8 - 6.1)
Sex <0.001 0.009 0.007
Male 2178 706 33.6 (30.7 - 36.5) 2173 457 21.3 (19.0 - 23.5) 1500 235 15.5 (13.3 - 17.8)
Female 1964 538 27.5 (24.8 - 30.2) 1949 347 17.5 (15.3 - 19.8) 1066 127 12.8 (10.3 - 15.3)
Age (years) <0.001 <0.001 0.004
18-24 379 127 34.7 (28.2 - 41.1) 377 91 24.5 (18.3 - 30.8) 207 35 19.8 (11.0 - 28.6)
25-39 1269 432 33.8 (30.4 - 37.2) 1263 285 21.9 (19.0 - 24.8) 942 146 15.3 (12.6 - 18.0)
40-54 1405 419 29.8 (26.8 - 32.8) 1396 275 19.0 (16.5 - 21.5) 1026 148 14.7 (12.2 - 17.2)
≥55 1089 266 27.1 (22.9 - 31.2) 1086 153 15.0 (12.1 - 18.0) 391 33 7.5 (5.1 - 9.9)
Level of 
education
<0.001 <0.001 <0.001
Low 1472 353 25.3 (21.6 - 29.0) 1470 201 14.0 (11.2 - 16.8) 800 81 11.4 (8.2 - 14.7)
Moderate 2149 683 32.6 (29.7 - 35.6) 2135 456 21.3 (18.9 - 23.7) 1380 204 14.9 (12.6 - 17.2)
High 498 197 40.5 (35.5 - 45.6) 494 141 29.6 (24.6 - 34.6) 370 74 20.2 (16.0 - 24.3)
Continued
Research Paper
Tobacco Induced Diseases 
Tob. Induc. Dis. 2018;16(Suppl 2):A11
https://doi.org/10.18332/tid/99117     
5
e-cigarette use was reported in Spain and Hungary: 
12.3% and 16.3% in public, 5.7% and 9.2% in indoor 
areas where smoking was banned, respectively. 
Among all respondents who knew about e-cigarettes 
and worked outside home (Table 2), 14.5% had 
observed in the last 30 days someone using e-cigarettes 
in indoor areas where they work. Again, the highest 
prevalence was reported in Greece (37.4%) and the 
lowest in Spain (4.0%) and Hungary (5.7%). 
Observed e-cigarette use was reported more 
frequently by male respondents, by younger age 
participants and those with higher level of education 
(Table 2). Noticing someone using e-cigarette in 
public was more frequently reported by current 
e-cigarette users (67.2%). Differences in prevalence 
among all groups analysed (by country, age, sex, 
level of education and e-cigarette use status) were all 
statistically significant (Table 2).
Self-reported frequency of exposure to SHA
Among all respondents in six EU MS, 177 reported 
currently using e-cigarettes and 1000 were former 
users. Most smokers from six EU MS who did not 
report currently using e-cigarettes declared being 
never exposed to SHA produced by others (63.3%). 
Nevertheless, some of them were exposed to SHA rarely 
or sometimes (33.1%) and 3.6% declared to be exposed 
often or very often (Table 3). The respondents from 
Greece and Poland were the ones who reported being 
exposed to SHA often or very often the most, 7.3% and 
5.6%, respectively; while in Spain this prevalence was 
the lowest (1.2%).
In public
(n=4142 )
Indoors where smoking is banned
(n=4122 )
Indoor areas at work
(n=2566 )
N n % 95% CI p N n % 95% CI p N n % 95% CI p
E-cigarette 
use status
<0.001 <0.001 <0.001
Current 174 119 67.2 (59.5 - 74.9) 173 74 41.0 (33.4 - 48.5) 106 29 27.3 (18.6 - 36.0)
Former 989 386 38.0 (34.5 - 41.5) 985 262 26.2 (22.8 - 29.6) 630 130 22.8 (18.6 - 26.9)
Never 2973 737 26.3 (23.4 - 29.2) 2958 466 16.0 (14.0 - 18.0) 1827 202 10.8 (8.9 - 12.7)
Table 2. Continued
CI: Confidence Intervals. *p-value: Pearson’s chi-squared test
Table 3. Self-reported frequency of secondhand e-cigarette aerosol exposure among smokers (non-current 
e-cigarette users) in six European Union Member States (N=3979 ), 2016
N
Never Rarely or sometimes Often or very often
n % 95% CI p n % 95% CI p n % 95% CI p
All 3979 2550 63.3 (60.7 - 65.8) 1279 33.1 (30.7 - 35.5) 150 3.6 (3.0 - 4.3)
Country <0.001 <0.001 <0.001
Germany 579 411 69.6 (63.7 - 75.5) 157 28.7 (23.1 - 34.4) 11 1.7 (0.5 - 2.8)
Greece 696 250 36.7 (28.2 - 45.4) 387 56.0 (47.7 - 64.3) 59 7.3 (4.9 - 9.6)
Hungary 642 499 79.2 (74.2 - 84.1) 129 18.7 (14.4 - 23.0) 14 2.1 (0.9 - 3.3)
Poland 615 274 43.9 (37.8 - 50.0) 303 50.5 (44.5 - 56.5) 38 5.6 (3.8 - 7.4)
Romania 630 454 66.6 (60.8 - 72.5) 160 29.6 (24.1 - 35.1) 16 3.8 (1.9 - 5.7)
Spain 817 662 82.3 (77.4 - 87.3) 143 16.5 (11.6 - 21.3) 12 1.2 (0.4 - 2.0)
Sex 0.008 0.030 0.179
Male 2094 1302 61.1 (58.1 - 64.1) 705 34.8 (32.0 - 37.7) 87 4.1 (3.2 - 5.0)
Female 1885 1248 66.1 (63.2 - 69.0) 574 30.9 (28.2 - 33.6) 63 3.0 (2.2 - 3.8)
Age (years) <0.001 <0.001 0.026
18-24 344 205 60.2 (54.2 - 66.3) 121 35.2 (29.4 - 40.9) 18 4.6 (2.2 - 6.9)
25-39 1225 724 59.2 (55.4 - 63.0) 453 36.9 (33.4 - 40.5) 48 3.9 (2.6 - 5.2)
40-54 1349 851 64.1 (60.9 - 67.3) 439 31.9 (29.0 - 34.8) 59 4.0 (2.8 - 5.1)
≥55 1061 770 69.3 (64.9 - 73.7) 266 28.5 (24.1 - 32.9) 25 2.2 (1.3 - 3.2)
Continued
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Slightly higher prevalence of rare or sometimes 
exposure to SHA was declared among males than 
females (34.8% vs 30.9%, respectively) (Table 3). 
Overall, any SHA exposure was more frequently 
reported among younger age groups (18–54 years) 
and by respondents with moderate and higher level 
of education. With regard to previous experience of 
e-cigarette use, the respondents who were former 
users declared more frequently to be exposed to SHA 
(44.5%) compared to never users (34.0%; Table 3).
Comfort level of using e-cigarettes around other 
people
Among participant smokers who also used 
e-cigarettes (dual users) at least once per month 
(n=109), 43.1% reported feeling comfortable or very 
comfortable using e-cigarette around other people, 
48.1% felt neutral and 8.8% uncomfortable or very 
uncomfortable (Table 4). The highest prevalence of 
the participants who declared feeling comfortable 
or very comfortable when they used e-cigarettes 
around other people was observed in Greece (59.1%) 
and Romania (48.7%), and the lowest in Hungary 
(26.1%) and Poland (28.6%). In all countries, except 
Greece and Romania, most users felt neutral when 
using e-cigarettes in the presence of others. 
Overall, 24 users of e-cigarettes reported receiving 
in total 35 negative reactions from different groups of 
bystanders about their e-cigarette use. Among them, 
15 respondents reported receiving negative reaction 
from one bystander group, seven users received 
negative reactions from two different bystanders’ 
Table 4. Comfort level of using an e-cigarette around other people (n=109 ), 2016
N
Comfortable or very 
comfortable Neutral
Uncomfortable or very 
uncomfortable
n % 95% CI n % 95% CI n % 95% CI
All 109 49 43.1 (32.4 - 53.8) 51 48.1 (37.6 - 58.6) 9 8.8 (3.0 - 14.6)
Country
Germany 31 13 39.4 (22.3 - 56.6) 17 58.1 (40.2 - 75.9) 1 2.5 (0.0 - 6.9)
Greece 31 21 59.1 (37.3 - 81.0) 7 26.5 (6.5 - 46.3) 3 14.4 (0.0 - 30.8)
Hungary 12 3 26.1 (0.0 - 52.3) 9 73.9 (47.7 - 100) 0 0 -
Poland 13 3 28.6 (5.6 - 51.5) 7 57.1 (31.9 - 82.4) 3 14.3 (0.0 - 29.5)
Romania 15 6 48.7 (12.6 - 84.7) 7 36.4 (4.7 - 68.2) 2 14.9 (0.0 - 33.0)
Spain 7 3 31.7 (0.0 - 72.2) 4 68.3 (27.8 - 100) 0 0 -
Negative reactions to 
e-cigarette use from:
Strangers 7 2 24.5 (0.0 - 54.4) 3 39.0 (3.7 - 74.2) 2 36.5 (2.2 - 70.9)
Work colleagues 5 2 54.9 (14.1 - 95.7) 2 31.2 (0.0 - 67.7) 1 13.9 (0.0 - 38.6)
Friends 13 7 60.7 (36.8 - 84.7) 4 26.5 (6.5 - 46.4) 2 12.8 (0.0 - 28.4)
Family 10 6 56.7 (26.0 - 87.5) 2 30.2 (0.0 - 61.5) 2 13.1 (0.0 - 28.5)
Table 3. Continued
N
Never Rarely or sometimes Often or very often
n % 95% CI p n % 95% CI p n % 95% CI p
Level of 
education
<0.001 <0.001 <0.001
Low 1427 1045 73.6 (70.4 - 76.8) 349 24.5 (21.3 - 27.8) 33 1.9 (1.2 - 2.6)
Moderate 2053 1238 58.6 (55.5 - 61.7) 715 36.5 (33.6 - 39.4) 100 4.9 (3.9 - 6.0)
High 476 253 51.7 (46.2 - 57.2) 207 44.9 (39.7 - 50.1) 16 3.4 (1.5 - 5.2)
E-cigarette use 
status
<0.001 <0.001 <0.001
Former 982 557 55.5 (51.9 - 59.1) 369 38.4 (34.9 - 41.8) 57 6.1 (4.7 - 7.6)
Never 2991 1993 66.0 (63.1 - 68.8) 906 31.2 (28.6 - 34.0) 92 2.8 (2.1 - 3.4)
CI: Confidence Intervals. *p-value: Pearson’s chi-squared test
CI: Confidence Intervals
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groups, and two users from three groups. In total, 
most of the negative reactions came from friends and 
family (Table 4). 
DISCUSSION
Overall, about a third of the respondents in our 
sample of cigarette smokers from six EU MS observed 
other people using e-cigarettes in public; about 20% 
observed e-cigarette use in indoor places where 
smoking conventional cigarettes was forbidden. 
Approximately 15% of respondents observed people 
using e-cigarettes at indoor workplaces. These 
results, overall as well as the country differences, 
are in line with self-reported frequency of exposure 
to SHA among those not using e-cigarettes, with 
slightly more than a third of respondents declaring to 
be exposed to the aerosols from e-cigarettes. These 
observations are also consistent with the differences 
in overall e-cigarette use prevalence among the 
countries included in current research1,14,15  and 
general support for the ban of e-cigarette use in 
public places16. 
The findings of the current study reflect a 
similar range of the potential level of exposure to 
SHA in public places as those reported for the UK 
and Australia, where 34% and 13%, respectively, 
of the respondents declared using e-cigarettes in 
smoke-free public places17. Moreover, the observed 
e-cigarette use in indoor workplaces ranged from 
4.0% in Spain to 37.4% in Greece, suggesting 
significant differences between the countries studied 
and potentially high levels of exposure to e-cigarette 
SHA at workplaces in some countries. These figures 
are in broad agreement with the parallel prevalence 
of exposure to secondhand tobacco smoke (SHS) in 
these countries18. An internet survey conducted in 
Japan that analysed e-cigarette use in restaurants 
and workplaces reported that almost 30% of the 
respondents used e-cigarettes in smoke-free 
restaurants and about a quarter in smoke-free 
workplaces19. In five out of six countries in the 
current study the observed e-cigarette use is lower 
than that observed in Japan. Nevertheless, exposure 
at these venues still exists, creating potentially 
harmful environments for bystanders. This also 
denotes a failure to comply with national regulations 
in the countries where such are in place. Taking into 
account that the TPD does not harmonise the rules 
on aerosol-free settings9, national regulations and 
their compliance play an important role in creating 
such environments.
Existing evidence indicates that exposure to SHA 
is not harmless20 and a significant proportion of 
bystanders may be exposed to toxicants from aerosols. 
One study using biomarkers of passive exposure 
reported that non-smokers passively exposed to SHA 
absorb nicotine21, and tobacco specific nitrosamines 
have been detected in the body fluids of bystanders 
exposed to SHA22. Another study estimated that, 
while the computed disability-adjusted life years 
attributed to SHA were relatively lower compared 
to those attributed to SHS and thirdhand smoke 
exposures, these were comparable with SHS and 
thirdhand smoke exposure for some components 
such as VOCs23. Therefore, regulations of e-cigarette 
use in public places should be developed and 
introduced to protect bystanders from involuntary 
secondhand and thirdhand exposure to aerosols24-26. 
Moreover, comprehensive aerosol-free policies are of 
importance to strengthen existing smoke-free laws 
as the use of e-cigarettes in public places may re-
normalise tobacco smoking, maintain dual use, and 
ultimately weaken previous efforts to create smoke-
free environments24,27. 
Taking into account that in four out of six countries 
included in the study legislation prohibiting 
e-cigarette use in public places is currently in force 
(Table 1); strengthening existing legislations and 
adherence to them should be stressed. Greece, where 
regulation on e-cigarette use came into force in 2010 
(Law 3868/2010)28, is the country with the highest 
prevalence of observed e-cigarette use in public 
places and reported SHA exposure. This may reveal 
other hidden aspects hindering adherence to current 
legislation, such as low level of enforcement and 
penalties application, degree of local government 
involvement, and tobacco industry investment in 
novel tobacco products29,30.
Similar to the findings on observed e-cigarette use, 
exposure to SHA was also reported more frequently 
among younger age groups and among smokers 
with higher educational level. These determinants 
are similar to those observed for e-cigarette use and 
awareness about e-cigarettes14. Children and youth 
are considered one of the most vulnerable groups 
to SHS31,32. Regarding socioeconomic determinants 
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of SHS exposure, a number of studies have shown 
that higher exposure is associated with lower level of 
education31,33. These differences could be attributed 
to the distinct sociodemographic characteristics of 
e-cigarette users. A few studies from the United 
States and Europe observed higher odds of ever 
e-cigarette use among adults with higher educational 
level34,35. This may suggest that bystanders exposed 
to SHA and active users of e-cigarettes share similar 
sociodemographic characteristics, different from 
those of active and passive smokers. This observation 
is in agreement with diffusion of innovation theory, 
according to which innovators and early adopters of 
new behaviours are male, with higher socioeconomic 
status compared to later adopters36, as previously 
observed for the spread of smoking37. Further 
research on these determinants is warranted to 
tailor policy regulations protecting bystanders from 
exposure to SHA that may be different from the 
policies targeting SHS. 
The majority of the smokers who also reported to be 
currently using e-cigarettes declared feeling neutral 
about e-cigarette use around other people. This is 
the case for all countries except Greece and Romania, 
where the majority of the users felt comfortable or 
very comfortable using e-cigarettes in the presence 
of bystanders, reaching 60% in Greece. This, on one 
hand, may reflect low levels of awareness about the 
health impact of SHA exposure among users and 
a lack of enforcement of current regulations38-40. 
On the other hand, this situation may represent a 
window of opportunity to increase awareness about 
potential harms among e-cigarette users and the 
general public41. Previous research indicates that 
perceived harm of exposure to SHA on individual 
health is associated with support of e-cigarette use 
restrictions in public spaces42; therefore, ultimately 
the efforts on increasing knowledge about the health 
effects of SHA exposure may increase support for 
aerosol-free policies and improve overall adherence 
to them43.
That many e-cigarette users felt comfortable 
or neutral to use e-cigarettes in the presence of 
bystanders may also indicate that e-cigarette use 
around others has been deemed as socially acceptable 
by the users. The variability of comfort level towards 
using e-cigarettes around other people at the 
country level could be attributed to the degree of 
peer influence on e-cigarette experimentation and 
use, and also the different regulatory environment of 
e-cigarette use and adherence to it that may promote 
more favourable attitudes towards e-cigarette use and 
its greater occurrence in public settings17,44,45. 
When interpreting the descriptive results about 
feeling comfortable with using e-cigarettes around 
other people and receiving negative reactions from 
others, one should take into account that the overall 
absolute numbers in these categories are very small. 
Nevertheless, the existing evidence in these aspects is 
scarce and should not be neglected. These results may 
indicate that those respondents who felt comfortable 
using e-cigarettes in the presence of others, overall 
receive more negative reactions than those feeling 
neutral or uncomfortable. This might be explained 
by the fact that the respondents feeling comfortable 
using e-cigarettes in the presence of others do it 
more often and, therefore, are more likely to receive 
more complaints. Also, these respondents received 
more complaints from family and friends rather than 
strangers. This may be explained by the settings 
where e-cigarettes were more commonly used and 
also by higher social acceptability towards e-cigarette 
use in some countries. However,  interpretation of 
these findings should be made with caution due to 
the small number of respondents and also the cross-
sectional nature of the survey, although reverse 
association is unlikely in this case.
The current study has further limitations. The 
sample comprised current cigarette smokers and, 
therefore, the results cannot be generalised to the 
general populations of the six countries in scope, 
but to the adult smoker population. Also, exposure 
to SHA was gathered only from non-users of 
e-cigarettes (former or never users) omitting the 
current e-cigarette users; therefore, exposure to SHA 
among smokers may be underestimated as the current 
e-cigarette users could be also exposed to SHA and 
this information was not collected; nonetheless, 
there were only 177 users of e-cigarette reporting 
current use. The comfort level of e-cigarette use 
around others was based on e-cigarette users in our 
samples of smokers and cannot be generalized to all 
e-cigarette users (comprising also those who do not 
concurrently smoke conventional cigarettes). This 
work is based on the Wave 1 of the cohort study and 
has a cross-sectional nature; therefore, precluding 
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any causal inference. However, the study is based 
on national representative samples of smokers in 
each country, providing valuable insights for this 
population. Given that smokers and e-cigarette 
users are less in favour of restrictions to e-cigarette 
use, it is of particular importance to gain a better 
understanding of exposure levels among this 
population and, therefore, obtain more insights for 
policy makers43. The reported results based on a 
sample of smokers might be a better estimation of 
overall SHA exposure, given that awareness about 
e-cigarettes is usually higher among smokers35 and 
they are more likely to notice e-cigarette use in their 
surroundings. Furthermore, the current study was 
conducted in six EU MS, providing knowledge on 
countries with different profiles (e-cigarette use 
prevalence, smoke-free and aerosol-free regulation, 
etc.). Even though this study is cross-sectional, 
this is the Wave 1 of the longitudinal study and 
will provide the basis for further trends analysis 
and prospective characterisation of SHA exposure 
determinants. Finally, this survey is based on a large 
ITC survey, enabling cross-country comparisons in 
the future.
CONCLUSIONS
A third of European smokers observed e-cigarette 
use in public places and a fifth at indoor areas where 
smoking is prohibited. The use of e-cigarettes at 
indoor areas of workplaces was also observed. More 
than a third of smokers were exposed to SHA. These 
findings suggest that a  non-negligible  part of 
the European population is exposed to SHA. The 
development and enforcement of public policies 
creating aerosol-free areas is necessary to protect 
bystanders’ health.   
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